Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Hannoun, Salem ^a   Bagory, Matthieu ^a   Durand Dubief, Francoise ^a,b   Ibarrola, Danielle ^c   Comte, Jean Christophe ^c   Confavreux, Christian ^b   Cotton, Francois ^a   Sappey Marinier, Dominique ^a,c  

^a UNIVERSITÉ DE LYON   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c CERMEP IMAGERIE DU VIVANT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; ARTICLE; AXONAL INJURY; BRAIN REGION; CENTRUM SEMIOVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATION; DIFFUSION; DIFFUSION TENSOR IMAGING; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSERVATIONAL STUDY; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; CLASSIFICATION; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY;

ADULT; ASPARTIC ACID; CHOLINE; DIFFUSION; DIFFUSION TENSOR IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84859135620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032525     Document Type: Article

References (36)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG, (2000) Multiple sclerosis. N Engl J Med 343: 938-952.
2. Compston A, McDonald IR, (2006) McAlpine's Multiple Sclerosis Philadelphia Churchill Livingstone, Elsevier, 4th ed.
3. Bjartmar C, Trapp BD, (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Cur Opin Neurol 14: 271-278.
4. Neema M, Stankiewicz J, Arora A, Guss ZD, Bakshi R, (2007) MRI in multiple Sclerosis: what's inside the toolbox? Neurotherapeutics 4: 602-617.
5. Rovaris M, Gass A, Bammer R, Hickman SJ, Ciccarelli O, et al. (2005) Diffusion MRI in multiple sclerosis. Neurology 65: 1526-1532.
6. Barkhof F, (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15 (3): 239-245.
7. Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, et al. (2006) Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter. Neuroimage 29 (2): 637-642.
8. Goldberg-Zimring D, Mewes AUJ, Maddah M, Warfield SK, (2005) Diffusion tensor magnetic resonance imaging in multiple sclerosis. J Neuroimaging 15: 68S-81S.
9. Ciccarelli O, Werring DJ, Barker GJ, Griffin CM, Wheeler-Kingshott CA, et al. (2003) A study of the mechanisms of normal appearing white matter damage in multiple sclerosis using diffusion tensor imaging. Evidence of Wallerian degeneration. J Neurol 250: 287-292.
10. Filippi M, Iannucci G, Cercignani M, Assunta Rocca M, Pratesi A, et al. (2000) A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol 57 (7): 1017-1021.
11. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH, (1999) Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 52 (8): 1626-1632.
12. Lowe J, Horenstein C, Hirsch JG, Marrie RA, Stone L, et al. (2006) Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis. Neuroimage 32: 1127-1133.
13. Hannoun S, Durand-Dubief F, Jalalzai W, Ibarrola D, Comte JC, et al. (2009) Characterization of the normal appearing white matter in multiple sclerosis by diffusion tensor imaging. IRBM 30 (4): 179-183.
14. Baslow MH, (2003) N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28: 941-953.
15. De Stefano N, Bartolozzi ML, Guidi L, Stromillo ML, Federico A, (2005) Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. J Neurol Sci 233: 203-208.
16. Caramanos Z, Narayanan S, Arnold D, (2005) 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain 128 (11): 2483-2506.
17. De Stefano N, Narayanan S, Francis G, Arnaoutelis R, Tartaglia MC, et al. (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58 (1): 65-70.
18. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50: 121-127.
19. Ratiney H, Sdika M, Coenradie Y, Cavassila S, Ormondt D, et al. (2005) Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed 18: 1-13.
20. Graveron-Demilly D, Diop A, Briguet A, Fenet B, (1993) Product-operator algebra for strongly coupled spin systems. J Magn Reson A 101: 233-239.
21. Bagory M, Durand-Dubief F, Ibarrola D, Comte JC, Cotton F, et al. (2011) Implementation of an absolute brain (1)H-MRS quantification method to assess different tissue alterations in multiple sclerosis. IEEE Trans Biomed Eng In press.
22. Souplet JC, (2009) Évaluation de l'atrophie et de la charge lésionnelle sur des séquences IRM de patients atteints de sclérose en plaques. PhD Thesis; Université de Nice Sophia-Antipolis.
23. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, et al. (2005) Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26: 132-140.
24. Rovaris M, Gass A, Bammer R, Hickman SJ, Ciccarelli O, et al. (2005) Diffusion MRI in multiple sclerosis. Neurology 65: 1526-1532.
25. Pierpaoli C, Barnet A, Pajevic S, Chen R, Penix LR, et al. (2001) Water diffusion changes in Wallerian degeneration and their dependence o white matter architecture. Neuroimage 13: 1174-1185.
26. De Stefano N, Iannucci G, Sormani MP, Guidi L, Bartolozzi ML, et al. (2002) MR correlates of cerebral atrophy in patients with multiple sclerosis. J Neurol 249: 1072-1077.
27. Urenjack J, Williams D, Gadian D, Noble M, (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 (3): 981-989.
28. Mader I, Roser W, Kappos L, Hagberg G, Seelig J, et al. (2000) Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. AJNR Am J Neuroradiol 21 (7): 1220-1227.
29. Hohlfeld R, (1997) Biotechnological agents for the immunotherapy of multiple sclerosis: principles, problems and perspectives. Brain 120 (5): 865-916.
30. Sigens PE, Irwan R, Hendrik Potze J, Mostert JP, De Keyser J, et al. (2005) Analysis of the human brain in primary progressive multiple sclerosis with mapping of the spatial distributions using 1H MR spectroscopy and diffusion tensor imaging. Eur Radiol 15: 1686-1693.
31. Oh J, Henry RG, Genain C, Nelson SJ, Pelletier D, (2004) Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry 75: 1281-1286.
32. Miller DH, Leary SM, (2007) Primary-progressive multiple sclerosis. Lancet neurol 6 (10): 903-912.
33. Phillips J, (2001) Re-thinking multiple sclerosis. Arch Neurol 58: 30-32.
34. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, et al. (1995) Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45: 1193-1198.
35. Schubert F, Seifert F, Elster C, Link A, Walzel M, et al. (2002) Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-beta therapy on absolute metabolite concentrations. MAGMA 14 (3): 213-222.
36. Pan JW, Coyle PK, Bashir K, Whitaker JN, Krupp LB, et al. (2002) Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy. Mult Scler 8 (3): 200-206.